IL‐33 can upregulate the expression of endothelial adhesion molecules (PECAM1 and CD34) and organoid adhesion molecules (KRT17), thus promoting angiogenesis (cell‐to‐cell adhesion) and tumor proliferation. Here, KRT17 is linked to neoplasm.